Purpose Respiratory disorders pose a major threat to the morbidity and mortality to public
health. Here we reviewed the nanotechnology based pulmonary drug delivery using …

Technological innovation has become an integral aspect of our daily life, such as wearable
and information technology, virtual reality and the Internet of Things which have contributed …

Abstract A Dry Powder Inhaler (DPI) is a technique as well as a device used to inhale
formulation which is in the form of dry powder, and is inhaled through the nose or mouth. It …

The rapid and non-invasive pulmonary drug delivery (PDD) has attracted great attention
compared to the other routes. However, nanoparticle platforms, like liposomes (LPs) and …

Despite advancements in the medical and pharmaceutical fields, tuberculosis remains a
major health problem globally. Patients do not widely accept the conventional approach to …

Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with
few systemic side effects. In addition, it is non-invasive and has good patient compliance …

Developing effective oral inhaled drug delivery treatment strategies for respiratory diseases
necessitates a thorough knowledge of the respiratory system physiology, such as the …

Adherence to inhaled treatments is a complex challenge for patients with chronic obstructive
pulmonary disease (COPD) and asthma, it not only involves following the prescribed …

Pulmonary administration of dry powder formulation presents several advantages in the
treatment of respiratory diseases. Since micronized drug particles are very cohesive and …

Dry powder inhalers (DPIs) are drug–device combination products where the complexity of
the formulation, its interaction with the device, and input from users play important roles in …